Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

New cancer pill almost doubles survival time for patients

Digest more
Top News
Overview
Impacts
 · 15h
New cancer pill almost doubles survival time for pancreatic patients during trial
A new once-daily pill almost doubled the survival time for patients battling an aggressive and advanced form of pancreatic cancer when compared to chemotherapy in a recent trial.

Continue reading

 · 13h
New pancreatic cancer pill nearly doubles survival time in breakthrough trial
 · 18h · on MSN
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
 · 6h
New pancreatic cancer experimental drug
A clinical trial for daraxonrasib showed it increased people’s lifespans compared to chemotherapy.

Continue reading

 · 17h
Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
 · 1d
Daily pill doubles survival time for pancreatic cancer patients
 · 1d
Experimental pill promises new hope for deadly pancreatic cancer
Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.

Continue reading

 · 1d
‘Breakthrough’ pill doubles life expectancy for pancreatic cancer patients
 · 1d
Revolution's pancreatic cancer drug doubles survival, boosts quality of life
Nanowerk
16m

Nanoparticles boost delivery of lung cancer drugs 30-fold

Nanoparticle delivery vehicle targets lung cancer drugs to the lungs, boosting bioavailability 30-fold while reducing exposure to healthy organs.
Public Broadcasting Service (PBS)
3d

Pancreatic cancer is deadly and difficult to treat. A new pill could change that

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
CURE
1d

GLP-1 Drugs May Improve Survival, Reduce Side Effects in Patients Receiving Immunotherapy

GLP-1 RA use was also tied to lower rates of immune-related side effects, caused by the immune system becoming overactive as a result of immunotherapy treatment. Patients taking GLP-1 drugs showed significantly lower rates of fever (pyrexia) at 3 years, with a 2.5 percentage-point risk reduction, and similar protective trends at 5 years.
20h

Cancer vaccine sustains 49% melanoma reduction after 5 years

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49%, a new study shows.
20h

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
WebMD
1y

BCG Treatment for Bladder Cancer

What Is BCG Treatment for Bladder Cancer? Bacillus Calmette-Guérin (BCG) is the main immunotherapy used to treat early-stage bladder cancer. Immunotherapy uses your immune system to fight cancer. BCG is a type of intravesical therapy, which means a liquid ...
13h

These lifestyle changes may help you live longer after a cancer diagnosis

How much do healthy lifestyle habits, such as diet and exercise, matter after a cancer diagnosis? Adopting healthy lifestyle behaviors - such as regularly engaging in moderate-intensity exercise or
  • Privacy
  • Terms